Pediatric pulmonary Flashcards

1
Q

Infant Respiratory Distress Syndrome is primarily seen in?

A
  • premature infants under 36 weeks
  • infants of diabetic mothers
  • multifetal pregnancies
  • c-section
  • family history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

primary cause of RDS?

A

Surfactant deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RDS signs within minutes of birth:

A
  • tachypnea
  • grunting
  • intercostal and subcostal retractions
  • nasal flaring
  • duskiness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RDS Physical exam:

A
  • diminished breath sounds
  • falling BP
  • Pallor
  • Progresses to: Apnea and mixed responses/metab acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RDS Diagnosis:

A
  • clinical
  • CXR- ground glassappearance
  • ABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

RDS DDx:

A

Early onset sepsis

  • pneumonia
  • cyanotic heart disease
  • persistent pulmonary HTN (normal X-rays with this)
  • Transient tachypnea of newborn (very common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Infant RDS prevention:

A

*Beta methasone 48 hours prior to delivery between 23 – 34 weeks (speeds up production of surfactant)
Should be administered to all pregnant women at 23 – 34 weeks gestation who are at increased risk of preterm delivery within the next 7 days to prevent or decrease the severity of neonatal RDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Infant RDS:

A
  • Careful and frequent monitoring

* Warm humidified O2 to keep arterial levels between 55 – 70 (sats >90%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

infant RDS Tx:

A

*If intubation needed at birth – infant should be given surfactant after initial stabilization
*nCPAP with selective use of intubation and surfactant therapy vs. routine intubation with prophylactic or early surfactant administration
Rescue surfactant for infants with hypoxic respiratory failure attributable to secondary surfactant deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bronchiolitis:

A
  • inflammation of bronchioles- usually from viral infection
  • ***most common lower respiratory tract infection in infants and children <2 yo
  • Most common causative agents: RSV Respiratory Syncytial Virus and adenovirus, human metapneumovirus, influenza, and para influenza
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchiolitis Dx:

A
  • Hx and PE

- Labs and radiological studies not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bronchiolitis presentation:

A
  • recent URI Sx’s: *rhinorrhea
  • Lower respiratory findings: *cough, *Tachypnea, *Increased Respiratory Effort
  • *Elevated RR- *earliest and most sensitive sign
  • nasal flaring, grunting
  • tachycardia due to dehydration and hypoxemia
  • apnea in very young infants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bronchiolitis Course:

A
  • Illness severity- determined by RR, work of breathing, hypoxia
  • Characteristic pattern- worsening clinical symptoms- peaking at 3-4 days of illness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bronchiolitis Dx studies:

A
  • not routinely recommended
  • CXR- hyperinflation, atelectasis, infiltrates, findings do not correlate with disease severity and don’t not guide management
  • Childeren > 60 days with fever - low risk of serious bacterial infection
  • Children <60 days with fever- evaluate for sepsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bronchiolitis management:

A
  • hydration
  • pxygenation
  • nasal suction
  • influenza antivirals
  • Ribavirin- in severe cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bronchiolitis prognosis:

A

-most recover without sequelae
-40% recurrent wheezing through age 5
-10% wheeze after age 5
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Leading cause of infant death from viral infections?

A

Respiratory Syncytial Virus (RSV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

by what age do most children have rsv by?

A

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RSV can happen isn any age and it appears as what?

A

common cold/ minor URI

-dangerous in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

RSV in boys verse girls.

A

1.5:1 in boys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

incubation of rsv

A

4 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how is rsv spread?

A
  • large droplets
  • remains on surfaces for days
  • high risk of nosocomial infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RSV clinical manifestations?

A

similar to bronchiolitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

who’s is most at risk for RSV?

A

Congenital heart disease with increase pulmonary bloodflow
Chronic lung disease, i.e. cystic fibrosis
Premature infants less than 6 months old (especially those with chronic lung disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

RSV labs:

A
  • rapid antigen tests

- diagnosis doesn’t alter tx course, more useful at beginning of season to see what RSV has started

26
Q

RSV complications:

A
  • otitis media

- bacterial pneumonia

27
Q

RSV prevention:

A
  • washing hands
  • respiratory/ contact isolation
  • cohort care
  • avoid exposure to tobacco smoke
  • Synagis
28
Q

Synagis-

A

-costly
-Infants born at less than 29 weeks in their first year of life
Infants born at less than 32 weeks with O2 requirement for at least 28 days after birth (Chronic Lung Disease
Infants less than 24 months of age with CLD still requiring medical intervention
Other categories based on risk factors

29
Q

Pediatric Asthma:

A
  • Chronic inflammatory condition of the lung airways resulting in episodic airflow obstruction
  • environmental, biological,andgenetic vulnerabilities
30
Q

Asthma Epi.

A
  • Male>Females
  • African-American>non African-American
  • More common in lower SES
  • One of the most common causes of ED visits
  • 80% of all asthmatic patients report disease onset prior to 6yo
31
Q

Asthma with recurrent wheezing:

A
  • Early Childhood

- Triggered by viral infections or upper airway

32
Q

Chronic asthma:

A
  • associated with allergy

- presists into late childhood and adulthood

33
Q

Asthma Clinical manifestations:

A

Intermittent dry coughing and expiratory wheezing
SOB and chest tightness in older children
*Symptoms worse at night

34
Q

Asthma triggers:

A
Physical exertion
Hyperventilation (laughing)
Cold or dry air
Airways irritants
Inhaled allergens
35
Q

Asthma physical findings:

A

Expiratory wheezing, prolonged expiratory phase
Decreased Breath Sounds (regional hypoinflation due to airways obstruction)
Retractions, accessory muscle use

36
Q

Asthma DDx:

A

*GER (gastroesophageal reflux)
Rhinosinusitis
Recurrent aspiration, tracheobronchomalacia, congenital anatomic abnormality of the airways

37
Q

Asthma Tx:

A

-NIH guidelines
-*Regular Assessment and Monitoring
Patient Education (triggers, bad times of your, what to do in asthma attack)
Control of Factors Contributing to Asthma Severity
Principles of Asthma Pharmacotherapy

38
Q

Asthma assessment and monitoring:

A
Assessing severity (intrinsic intensity of disease)
*Intermittent
*Persistent – mild, moderate, severe
Degree to which symptoms, ongoing functional impairments and risk of adverse events are minimized and goals of therapy are met
3 levels of control
Well-controlled
Not well-controlled
Very poorly controlled
39
Q

asthma pt education:

A
Basic education about the pathogenesis of asthma
Expectations of good asthma control
Written asthma management plan
Daily routine plan
Action plan to manage worsening asthma
40
Q

controlling asthma severity:

A

*Eliminating and reducing problematic environmental exposures
Minimize allergen exposures
Remove airway irritants – tobacco smoke, dusts, strong odors
Treat co-morbid conditions – GER, sinusitis

41
Q

2 acute inflammatory upper airways obstruction:

A

Croup (laryngotracheobronchitis)

Epiglottitis

42
Q

Croup clinical manifestations:

A

*URI symptoms for 1 – 3 days before the symptoms of upper airway obstruction
barky cough, hoarseness, inspiratory stridor
*Worse at night
Crying and agitation aggravate symptoms and signs
Occurs in 3 month – 5 years of age, peak in second year of life

43
Q

Croup Epi:

A

Usually due to parainfluenza viruses (75%)
Also: influenza, RSV, adenovirus
Seen in 3mo – 5 year olds with peak in 2nd year of life
Boys > girls
Usually late fall and winter

44
Q

Croup Dx:

A
  • clinical

- steeple sign on X-ray if done (slide 55)

45
Q

Croup airway management:

A

Usually managed at home
Cool mist
Steamy bathroom for exacerbations

46
Q

Croup hospital/ED management:

A

Nebulized racemic epinephrine

Corticosteroids

47
Q

When to hospitalize for croup:

A
Progressive stridor
Severe stridor at rest
Respiratory distress
Hypoxia
Cyanosis
Depressed mental status
48
Q

Croup - acute

A

*Always associated with viral illness of upper respiratory tract

49
Q

Croup - spasmodic (recurrent)

A
  • Allergic component

* Resolves rapidly with treatment

50
Q

Acute Epiglottitis:

A

Acute, fulminating course of high fever, sore throat, dyspnea, rapidly progressing respiratory obstruction
Much less prevalent nowadays since introduction of HiB vaccine
-seen in unimmunized

51
Q

Acute epiglottis clinical manifestations:

A

-Tripod position
-Otherwise healthy child suddenly develops a sore throat and fever (they look sick)
Within few hours – toxic appearing, difficulty swallowing and breathing
Drooling
*Stridor is a late finding and suggests near-complete airway obstruction

52
Q

Epiglottis Dx:

A

Visualization of a large, “cherry-red” swollen epiglottitis
Should occur in controlled environment – i.e. operating room
Should only be performed by someone capable of maintaining airway – i.e. ENT or anesthesiologist
-*do not agitate child, leave in parents lap to examine

53
Q

Epiglottitis management:

A

*Establish an airway – intubation
*As many as 6% of children without an artificial airway die
Oxygen
Culture blood, epiglottis
Antibiotics
Ceftriaxone, cefixime or combo of ampicillin and sulbactam

54
Q

DDX of acute inflammatory upper airway obstruction:

A

*Diphtheric croup
*Aspiration of foreign body (no feer, not sick)
Retropharyngeal or pertonsillar abscess
Extrinsic compression of the airway (laryngeal web, vascular ring) (usually not acute onset)

55
Q

Pertussis:

A

Whooping cough
Bordetella pertussis
Prevented by pertussis vaccine

56
Q

Pertussis clinical manifestations:

A
6 week course
Catarrhal
Incubation period 3 – 12
Nondistinctive symptoms of congestion and rhinorrhea
-6 week course continued
*Paroxysmal
Cough at first is dry, intermittent, irritative hack
Evolves into inexorable paroxysms – hallmark of the disease
Number and intensity of paroxysms progresses over days to a week and then plateaus for days to weeks
Convalescent
Slow resolution of paroxysmal episodes
Infant with pertussis
Infant in ICU with Pertussis
Child with pertussis
Toddler with whooping cough
-***kids under 3 months, do not whoop***
57
Q

Pertussis Dx:

A

Suspect in patient who has predominant complaint of cough *especially in the absence of fever, malaise, myalgia, exanthema or sore throat

  • Leukocytosis with absolute lymphocytosis
  • Culture is gold standard, but do not wait on results to treat*
  • Reportable disease
58
Q

Pertussis Tx goals:

A
  • Limit number of paroxysms, observe the severity of cough, provide assistance when necessary, maximize rest and recovery
  • Antimicrobial agents – Erythromycin or azythromycin*
59
Q

Pertussis and antibiotics:

A

may ameliorate disease in catarrhal stage, will not alter course in paroxysmal stage but will limit spread*

60
Q

When to hospitalize with pertussis:

A
  • Infants under 3 months of age
  • 3- 6 months with severe paroxysms
  • Premature infants or children with underlying cardiac, pulmonary, muscular or neurologic disorders
61
Q

Pertussis Complications:

A
  • Mortality – 1 % in < 2 month olds
  • Hospitalization
  • Pneumonia
  • Seizures
  • Apnea
  • Secondary infections
62
Q

Pertussis prevention:

A

Vaccine